Search research articles
Contact Us
Filters
Showing results (111-120 of 259) with videos related to
Page
of 26
Sort By:
DNA and Cell Biology
|
January 1, 1991
Heterogeneity of mutations in the acid beta-glucosidase gene of Gaucher disease patients
T E Latham, B D Theophilus, G A Grabowski, et al.
DNA (Mary Ann Liebert, Inc.)
|
October 1, 1988
Gaucher disease type 1: cloning and characterization of a cDNA encoding acid beta-glucosidase from an Ashkenazi Jewish patient
P N Graves, G A Grabowski, R Eisner, et al.
Human Molecular Genetics
|
August 7, 2001
Enzyme therapy for lysosomal acid lipase deficiency in the mouse
H Du, S Schiavi, M Levine, et al.
Biochimica Et Biophysica Acta
|
September 29, 1993
Synthesis and use of novel fluorescent glycosphingolipids for estimating beta-glucosidase activity in vitro in the absence of detergents and subtyping Gaucher disease variants following administration into intact cells
V Agmon, S Cherbu, A Dagan, et al.
Biochimica Et Biophysica Acta
|
September 2, 1987
Human acid beta-glucosidase: use of inhibitors, alternative substrates and amphiphiles to investigate the properties of the normal and Gaucher disease active sites
K Osiecki-Newman, D Fabbro, G Legler, et al.
The American Journal of Pathology
|
May 11, 1999
Murine acid alpha-glucosidase: cell-specific mRNA differential expression during development and maturation
E Ponce, D P Witte, R Hirschhorn, et al.
American Journal of Human Genetics
|
June 1, 1993
Phenotype/genotype correlations in Gaucher disease type I: clinical and therapeutic implications
A Sibille, C M Eng, S J Kim, et al.
The Journal of Biological Chemistry
|
July 19, 1996
Proteolytic processing patterns of prosaposin in insect and mammalian cells
T Leonova, X Qi, A Bencosme, et al.
Clinical Genetics
|
May 1, 1985
Glycosphingolipid studies of visceral tissues and brain from type 1 Gaucher disease variants
O Nilsson, G A Grabowski, M D Ludman, et al.
Clinical Pharmacokinetics
|
August 4, 2006
Pharmacokinetics, pharmacodynamics and safety of febuxostat, a non-purine selective inhibitor of xanthine oxidase, in a dose escalation study in healthy subjects
Reza Khosravan, Brian A Grabowski, Jing-Tao Wu, et al.
Page
of 26
Search research articles
Search
Showing results (111-120 of 259) with videos related to
Sort By:
Page
of 26
DNA and Cell Biology
|
January 1, 1991
Heterogeneity of mutations in the acid beta-glucosidase gene of Gaucher disease patients
T E Latham, B D Theophilus, G A Grabowski, et al.
DNA (Mary Ann Liebert, Inc.)
|
October 1, 1988
Gaucher disease type 1: cloning and characterization of a cDNA encoding acid beta-glucosidase from an Ashkenazi Jewish patient
P N Graves, G A Grabowski, R Eisner, et al.
Human Molecular Genetics
|
August 7, 2001
Enzyme therapy for lysosomal acid lipase deficiency in the mouse
H Du, S Schiavi, M Levine, et al.
Biochimica Et Biophysica Acta
|
September 29, 1993
Synthesis and use of novel fluorescent glycosphingolipids for estimating beta-glucosidase activity in vitro in the absence of detergents and subtyping Gaucher disease variants following administration into intact cells
V Agmon, S Cherbu, A Dagan, et al.
Biochimica Et Biophysica Acta
|
September 2, 1987
Human acid beta-glucosidase: use of inhibitors, alternative substrates and amphiphiles to investigate the properties of the normal and Gaucher disease active sites
K Osiecki-Newman, D Fabbro, G Legler, et al.
The American Journal of Pathology
|
May 11, 1999
Murine acid alpha-glucosidase: cell-specific mRNA differential expression during development and maturation
E Ponce, D P Witte, R Hirschhorn, et al.
American Journal of Human Genetics
|
June 1, 1993
Phenotype/genotype correlations in Gaucher disease type I: clinical and therapeutic implications
A Sibille, C M Eng, S J Kim, et al.
The Journal of Biological Chemistry
|
July 19, 1996
Proteolytic processing patterns of prosaposin in insect and mammalian cells
T Leonova, X Qi, A Bencosme, et al.
Clinical Genetics
|
May 1, 1985
Glycosphingolipid studies of visceral tissues and brain from type 1 Gaucher disease variants
O Nilsson, G A Grabowski, M D Ludman, et al.
Clinical Pharmacokinetics
|
August 4, 2006
Pharmacokinetics, pharmacodynamics and safety of febuxostat, a non-purine selective inhibitor of xanthine oxidase, in a dose escalation study in healthy subjects
Reza Khosravan, Brian A Grabowski, Jing-Tao Wu, et al.
Page
of 26